BAX
What one share of Baxter International holds
Surgical and Medical Instruments and Apparatus
Baxter International Inc., through our subsidiaries, provides a broad portfolio of essential healthcare products, including sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices.
Baxter International’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $22.29 |
|---|---|
| Profit | −$2.07 |
| Dividends | $0.20 |
| Cash and investments | $4.16 |
| Debt | $18.30 |
| Book value | $12.00 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $18.44 | $9.01 | $1.30 | $1.70 | $0.51 | $15.35 |
| 2017 | $19.07 | $1.08 | $1.11 | $1.98 | $0.61 | $16.89 |
| 2018 | $20.33 | $2.83 | $1.21 | $2.49 | $0.73 | $15.30 |
| 2019 | $21.89 | $1.93 | $1.34 | $2.71 | $0.85 | $15.54 |
| 2020 | $22.58 | $2.13 | $1.37 | $2.24 | $0.95 | $17.20 |
| 2021 | $23.91 | $2.53 | $1.36 | $3.01 | $1.08 | $18.07 |
| 2022 | $19.95 | −$4.83 | $0.75 | $1.65 | $1.15 | $11.56 |
| 2023 | $20.39 | $5.23 | $0.85 | $2.55 | $1.16 | $16.55 |
| 2024 | $20.85 | −$1.27 | $0.87 | $1.12 | $1.04 | $13.61 |
| 2025 | $21.92 | −$1.87 | $1.00 | $0.65 | $0.52 | $11.91 |